Fig. 1From: Discovery of novel 2,3,4,5-tetrahydrospiro[benzo[c]azepine-1,1’-cyclohexan]-5-ol derivatives as PARP-1 inhibitorsThe structures of erythrina, talazoparib, fluzoparib, rucaparib and 5 H-dibenzo[b,e]azepine-6,11-dione derivativesBack to article page